OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NKT59

Nakornthon Hospital PCL

Healthcare Facilities & ServicesVerified

Nakornthon Hospital PCL maintains a strong capital structure with a low debt-to-equity ratio of 0.04, indicating minimal leverage and a conservative approach to financing. However, the company's liquidity position is characterized as medium, with a current ratio of 1.19, suggesting that it has just enough current assets to cover its current liabilities. The company's free cash flow is negative at -601,200,500 THB, which is a concern as it indicates that the company is spending more on capital expenditures than it is generating in operating cash flow. In terms of profitability, Nakornthon Hospital PCL demonstrates a return on equity of 9.68% and a return on assets of 7.49%, which are metrics that reflect the company's efficiency in generating profits from its equity and total assets, respectively. These figures should be compared against the industry median to determine if the company is outperforming or underperforming its peers. The company's operating income of 258,210,520 THB and net income of 195,351,900 THB indicate a healthy bottom line, but the gross profit of 564,414,840 THB suggests that the company is managing its cost of goods sold effectively. The company's revenue is distributed across two reportable segments: hospital operations and other businesses that support hospital operations, including the distribution of health and cosmetic products, facility management, and restaurant services. The hospital operations segment is the primary source of revenue, while the other businesses segment contributes to the company's overall financial performance. The company's geographic exposure is primarily within Thailand, with no significant international operations reported. Looking at the company's growth trajectory, the outlook for the current fiscal year and the next fiscal year is not explicitly provided, but the company's historical revenue of 1,986,365,540 THB indicates a stable revenue base. The company's capital expenditure of -932,369,280 THB is a significant outlay, which may be indicative of ongoing investments in infrastructure or expansion. The risk assessment indicates a medium liquidity risk and a low dilution risk, with a key flag noting that net cash is negative after subtracting total debt. Recent events and filings have not been detailed in the provided data, but the company's financial snapshot and risk assessment suggest that it is maintaining a cautious approach to its financial management. The company's liquidity position and capital structure are key areas to monitor for any changes that could affect its financial stability.

30-day price · NKT-0.14 (-3.4%)
Low$3.92High$4.22Close$3.96As of15 May, 00:00 UTC
Profile
CompanyNakornthon Hospital PCL
TickerNKT.BK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Nakornthon Hospital PCL operates as a Thailand-based hospital company, providing a range of specialty medical services and ancillary health and wellness offerings.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a high confidence level of 0.92.

Nakornthon Hospital PCL maintains a strong capital structure with a low debt-to-equity ratio of 0.04, indicating minimal leverage and a conservative approach to financing. However, the company's liquidity position is characterized as medium, with a current ratio of 1.19, suggesting that it has just enough current assets to cover its current liabilities. The company's free cash flow is negative at -601,200,500 THB, which is a concern as it indicates that the company is spending more on capital expenditures than it is generating in operating cash flow. In terms of profitability, Nakornthon Hospital PCL demonstrates a return on equity of 9.68% and a return on assets of 7.49%, which are metrics that reflect the company's efficiency in generating profits from its equity and total assets, respectively. These figures should be compared against the industry median to determine if the company is outperforming or underperforming its peers. The company's operating income of 258,210,520 THB and net income of 195,351,900 THB indicate a healthy bottom line, but the gross profit of 564,414,840 THB suggests that the company is managing its cost of goods sold effectively. The company's revenue is distributed across two reportable segments: hospital operations and other businesses that support hospital operations, including the distribution of health and cosmetic products, facility management, and restaurant services. The hospital operations segment is the primary source of revenue, while the other businesses segment contributes to the company's overall financial performance. The company's geographic exposure is primarily within Thailand, with no significant international operations reported. Looking at the company's growth trajectory, the outlook for the current fiscal year and the next fiscal year is not explicitly provided, but the company's historical revenue of 1,986,365,540 THB indicates a stable revenue base. The company's capital expenditure of -932,369,280 THB is a significant outlay, which may be indicative of ongoing investments in infrastructure or expansion. The risk assessment indicates a medium liquidity risk and a low dilution risk, with a key flag noting that net cash is negative after subtracting total debt. Recent events and filings have not been detailed in the provided data, but the company's financial snapshot and risk assessment suggest that it is maintaining a cautious approach to its financial management. The company's liquidity position and capital structure are key areas to monitor for any changes that could affect its financial stability.
Key takeaways
  • Nakornthon Hospital PCL has a low debt-to-equity ratio, indicating a conservative capital structure.
  • The company's return on equity and return on assets are positive, suggesting efficient use of capital.
  • The company's free cash flow is negative, which may signal a need for careful capital management.
  • The company's liquidity position is medium, with a current ratio just above 1.
  • The company's capital expenditure is substantial, which may be a sign of investment in growth or infrastructure.
  • # RATIONALES
  • margin_outlook_rationale: The company's gross profit margin is stable, indicating consistent cost management.
  • rd_outlook_rationale: No specific R&D outlook is provided, but the company's focus on medical services suggests ongoing investment in healthcare innovation.
Financial snapshot
PeriodHA-latest
CurrencyTHB
Revenue$1.99B
Gross profit$564.4M
Operating income$258.2M
Net income$195.4M
R&D
SG&A
D&A
SBC
Operating cash flow$380.6M
CapEx-$932.4M
Free cash flow-$601.2M
Total assets$2.61B
Total liabilities$587.9M
Total equity$2.02B
Cash & equivalents$20.00
Long-term debt$85.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.02B
Net cash-$85.8M
Current ratio1.2
Debt/Equity0.0
ROA7.5%
ROE9.7%
Cash conversion1.9%
CapEx/Revenue-46.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
MetricNKTActivity
Op margin13.0%11.5% medp25 9.9% · p75 15.0%above median
Net margin9.8%8.6% medp25 6.3% · p75 12.4%above median
Gross margin28.4%28.8% medp25 28.8% · p75 28.8%bottom quartile
CapEx / revenue-46.9%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity4.0%71.3% medp25 60.7% · p75 71.3%bottom quartile
Observations
IR observations
Mean price target12.20 THB
Median price target12.20 THB
High price target12.20 THB
Low price target12.20 THB
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 05:52 UTC#66906a96
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 05:54 UTCJob: 80c038d1